Prana Biotechnology Ltd (NASDAQ:PRAN)
| 5.79 Data as of Dec 04 |  +0.11 / +1.94%Today’s Change | 2.03 Today|||52-Week Range 6.50 | +163.18% Year-to-Date |
Latest PRAN News | Press Releases
| 3 Drugmakers on the Move Nov 22 / MotleyFool.com |
Today’s Trading
| Previous close | 5.68 |
| Today’s open | 5.80 |
| Day’s range | 5.56 - 5.80 |
| Volume | 328,656 |
| Average volume (3 months) | 648,324 |
| Market cap | $231.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 12/04/2013
Growth & Valuation
| Earnings growth (last year) | -24.33% |
| Earnings growth (this year) | -74.66% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 16.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMBIAmbit Biosciences Co... | -4.24 | -33.13% |
| SUPNSupernus Pharmaceuti... | +0.19 | +2.73% |
| POZNPOZEN Inc | -0.02 | -0.25% |
| NYMXNymox Pharmaceutical... | -0.03 | -0.45% |
Data as of 4:00pm ET, 12/04/2013
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$8.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Executive Chairman & Chief Executive Officer Geoffrey Paul Kempler |
Chief Operating Officer Dianne Angus |
Corporate headquarters Parkville, Victoria (vic) |
Forecasts
